Bausch Health CFO to Present at J.P. Morgan Leveraged Finance Conference
Event summary
- Bausch Health CFO Jean-Jacques Charhon will attend the J.P. Morgan Global Leveraged Finance Conference from March 2–4, 2026.
- The event will take place in Miami Beach, Florida.
- Bausch Health is a diversified pharmaceutical company with a controlling interest in Bausch + Lomb Corporation.
- The company operates in multiple therapeutic areas including gastroenterology, dermatology, and eye health.
The big picture
Bausch Health's participation in the J.P. Morgan Global Leveraged Finance Conference underscores its focus on engaging with investors to discuss its financial strategy. The company's diversified portfolio and controlling interest in Bausch + Lomb Corporation position it as a key player in the pharmaceutical and healthcare sectors. The event provides an opportunity to assess the company's approach to leveraged finance amid broader industry trends.
What we're watching
- Investor Sentiment
- How Bausch Health's presentation will impact investor confidence amid its diversified portfolio.
- Debt Strategy
- Whether the company will address its leveraged finance strategy in the context of the conference.
- Market Positioning
- The pace at which Bausch Health can solidify its position in the global pharmaceutical market.
Related topics